A large electronic health record cohort study found that patients who used phentermine beyond three months did not show increased cardiovascular adverse events, including no elevated risk of heart attack, stroke, or death over three years of follow-up
In medical terms, microdosing generally refers to taking a dose lower than the lowest FDA-approved dose of a medication
Hence, the dynamic study of incretin drugs may be the center of future research
Tirzepatide's SURMOUNT-1 curve flattened earlier at a lower ceiling, consistent with a mechanism that primarily caps intake rather than also raising expenditure
Recognizing these patterns is key to identifying at-risk patients, anticipating complications, and guiding safe management
Tirzepatide: Positioned as a dual GIP and GLP-1 receptor agonist, Tirzepatide offers a novel approach to diabetes management